Inovio Pharmaceuticals (INO)

Add to Watchlists Create an Alert
0.71 +0.02  +2.90%   AMEX May 24, 8:00PM BATS Real time Currency in USD

Inovio Pharmaceuticals R&D Expense Quarterly:

4.443M for Dec. 31, 2012
View Full Chart

Inovio Pharmaceuticals R&D Expense Quarterly Chart

    Inovio Pharmaceuticals Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 4.443M
    Sept. 30, 2012 4.972M
    June 30, 2012 4.527M
    March 31, 2012 4.043M
    Dec. 31, 2011 4.158M
    Sept. 30, 2011 6.988M
    June 30, 2011 4.464M
    March 31, 2011 4.422M
    Dec. 31, 2010 4.492M
    Sept. 30, 2010 2.951M
    June 30, 2010 3.083M
    March 31, 2010 2.731M
    Dec. 31, 2009 3.851M
    Sept. 30, 2009 3.412M
    June 30, 2009 1.181M
    March 31, 2009 0.9637M
    Dec. 31, 2008 1.200M
    Sept. 30, 2008 1.274M
    June 30, 2008 1.679M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro
    June 30, 2000 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    INO R&D Expense Quarterly Benchmarks

    Companies
    Titan Pharmaceuticals 2.573M
    Enanta Pharmaceuticals 4.798M
    Infinity Pharmaceuticals 40.02M

    INO R&D Expense Quarterly Rankings

    Overall 88th percentile
    867 of 7600
    Sector 62nd percentile
    248 of 653 in Healthcare
    Industry 52nd percentile
    113 of 238 in Biotechnology

    INO R&D Expense Quarterly Range, Past 5 Years

    Minimum 0.9637M Mar 2009
    Maximum 6.988M Sep 2011
    Average 3.412M